Cytomaxes
Peptide bioregulators Cytomaxes are peptide bioregulators duration of active life. created based on natural animal-derived Cytomaxes are recommended for use
based on natural peptides polypeptides. An exclusive high-efficien- after a course of Cytogens to consoli-
cy technology for isolating low-molecu- date the achieved effect and maintain
lar-weight peptide fractions from animal positive dynamics, as well as a stand-
organs and tissues was developed by alone program for deep recovery and
the staff of the St. Petersburg Institute health maintenance. The positive results
of Bioregulation and Gerontology under of using Cytomaxes have been prov-
the guidance of RAS academician V.Kh. en by many years of clinical research in
Khavinson. This technology formed the leading medical institutions in Russia
basis of a new class of peptide prepara- and abroad. These peptide bioregulators
tions, collectively known as "Cytomaxes." are safe to use as they are not medicinal
The principle of action of Cytomaxes products, have no side effects or with-
is based on tissue specificity: a peptide drawal syndrome, allowing them to be
complex isolated from a specific organ used in courses throughout life to main-
acts precisely on the cells of the corre- tain health and active longevity.
sponding organ in the human body. Pep-
tides derived from muscle tissue nor-
malize muscle metabolism; those isolat-
ed from the vascular wall affect vascu-
lar cells; brain peptides target neurons;
liver peptides support hepatocytes, and
so on. This selective mechanism of ac-
tion ensures targeted restoration of the
functions of specific organs and systemsUsage recommendations for
Cytomaxes: without affecting other body tissues.
Bioregulators created based on natu-
1-2 capsules 1-2 times a day with meals. ral peptides help slow down premature
Duration of intake — 1-3 months. It is aging changes and normalize metabol-advisable to conduct a repeat course after
ic processes in the body's cells, initiating1-3 months.
their natural renewal process. With reg-
ular use, Cytomaxes help reduce the risk
20/60 capsules of 0.215 g of oncological diseases and increase the
P e p t i d e s ® | A n t i - a g i n g t e c h n o l o g i e s o f p e p t i d e a n d n o n - p e p t i d e b i o r e g u l a t i o n || 37-А
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.